U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TOZINAMERAN EXPRESSED SARS COV2 SPIKE-PROTEIN VACCINE ANTIGEN
BP87QBQ8LZ
Other
General
Record Details
Names
3
Identifiers
1
Concept Definition
Relationships
3
TOZINAMERAN EXPRESSED SARS COV2 SPIKE-PROTEIN VACCINE ANTIGEN
BP87QBQ8LZ
Other
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Concept
Record UNII
BP87QBQ8LZ
Record Status
Validated (UNII)
Record Version
8
7
6
5
4
3
2
1
Names
3
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TOZINAMERAN EXPRESSED SARS COV2 SPIKE-PROTEIN VACCINE ANTIGEN
Common Name
English
EXPRESSED SARS-COV-2 SPIKE GLYCOPROTEIN FROM M-1273 VACCINE
Common Name
English
SPIKE GLYCOPROTEIN (SARS-COV-2/K986P/V987P)
Common Name
English
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
1
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
BP87QBQ8LZ
PRIMARY
Showing 1 to 1 of 1 entries
Previous
1
Next
Concept Definition
This is a non-substance concept
Relationships
3
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
5085ZFP6SJ
Tozinameran
VECTOR->EXPRESSED PROTEIN
Amount:
6FH8H9CL41
PIDACMERAN
VECTOR->EXPRESSED PROTEIN
Comments:
Translated protein from STN
Amount:
EPK39PL4R4
ELASOMERAN
VECTOR->EXPRESSED PROTEIN
Amount:
Showing 1 to 3 of 3 entries
Previous
1
Next
This is a non-substance concept